EDITAS MEDICINE, INC. (EDIT) Net margin 2016–2025
EDITAS MEDICINE, INC. (EDIT) net profit margin by fiscal year — reported net income divided by reported revenue.
-395.0%FY2025 · since FY2016: -1605.5% → -395.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -395.0% | +338.7 pp |
| FY2024 | -733.7% | -537.6 pp |
| FY2023 | -196.1% | +922.1 pp |
| FY2022 | -1118.3% | -364.7 pp |
| FY2021 | -753.6% | -625.8 pp |
| FY2020 | -127.8% | +523.6 pp |
| FY2019 | -651.4% | -307.2 pp |
| FY2018 | -344.3% | +532.2 pp |
| FY2017 | -876.5% | +729.0 pp |
| FY2016 | -1605.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More EDIT financial trends
EDIT RevenueEDIT Net incomeEDIT Gross profitEDIT Gross marginEDIT Operating incomeEDIT Operating marginEDIT Operating cash flowEDIT Free cash flowEDIT Capital expendituresEDIT Return on equityEDIT Stock buybacksEDIT Dividends paidEDIT Total assetsEDIT Total liabilitiesEDIT Shareholders’ equityEDIT overview →